Bordetella pertussis and outer membrane vesicles
- 1 September 2022
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 117 (4) , 342-355
Abstract
Bordetella pertussis is the causative agent of a respiratory infection called pertussis (whooping cough) that can be fatal in newborns and infants. The pathogen produces a variety of antigenic compounds which alone or simultaneously can damage various host cells. Despite the availability of pertussis vaccines and high vaccination coverage around the world, a resurgence of the disease has been observed in many countries. Reasons for the increase in pertussis cases may include increased awareness, improved diagnostic techniques, low vaccine efficacy, especially acellular vaccines, and waning immunity. Many efforts have been made to develop more effective strategies to fight against B. pertussis and one of the strategies is the use of outer membrane vesicles (OMVs) in vaccine formulations. OMVs are attracting great interest as vaccine platforms since they can carry immunogenic structures such as toxins and LPS. Many studies have been carried out with OMVs from different B. pertussis strains and they revealed promising results in the animal challenge and human preclinical model. However, the composition of OMVs differs in terms of isolation and purification methods, strains, culture, and stress conditions. Although the vesicles from B. pertussis represent an attractive pertussis vaccine candidate, further studies are needed to advance clinical research for next-generation pertussis vaccines. This review summarizes general information about pertussis, the history of vaccines against the disease, and the immune response to these vaccines, with a focus on OMVs. We discuss progress in developing an OMV-based pertussis vaccine platform and highlight successful applications as well as potential challenges and gaps.Keywords
Funding Information
- there is no funding
This publication has 129 references indexed in Scilit:
- Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, FranceEmerging Infectious Diseases, 2013
- Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial LifeInfection and Immunity, 2012
- Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesiclesFEBS Letters, 2012
- Horizontal Transfer of the OXA-24 Carbapenemase Gene via Outer Membrane Vesicles: a New Mechanism of Dissemination of Carbapenem Resistance Genes in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2011
- Bacillus anthracis produces membrane-derived vesicles containing biologically active toxinsProceedings of the National Academy of Sciences, 2010
- Periplasmic domain of the sensor-kinase BvgS reveals a new paradigm for the Venus flytrap mechanismProceedings of the National Academy of Sciences, 2010
- Release of outer membrane vesicles by Gram‐negative bacteria is a novel envelope stress responseMolecular Microbiology, 2006
- Membrane Vesicles: an Overlooked Component of the Matrices of BiofilmsJournal of Bacteriology, 2006
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005
- Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cellsThe EMBO Journal, 2004